← Evidence map

ArticleTranslational lung cancer research2026

Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?

Jiefei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42433228